• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

10,015
2,295
1,799
1,792
1,739

COUNTRY

808
620
258
244
227

CATEGORIES

  • 718
  • 150
  • 951
  • 1,082
    • 108
  • 355
  • 252
  • 200
  • 64
  • 372
  • 634
  • 1,026
  • 1,615
  • 625
  • 869
  • 1,564
  • 2,448
    • 576
    • 122
    • 558
    • 80
    • 530
    • 43
    • 507
    • 17
    • 19
    • 25
  • 505
  • 704
  • 0
  • 135

PRICE

5,756
10,329
15,043
22,836

PUBLISHED

1,590
2,354
6,646
22,836

PRODUCT TYPE

18,446
3,187
862
142
73
46
24
21
21
8
6

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Burns - Pipeline Review, H1 2013 Burns - Pipeline Review, H1 2013 - Product Thumbnail Image

Burns - Pipeline Review, H1 2013

Burns – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Burns - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM
Indolent Lymphoma - Pipeline Review, H1 2013 Indolent Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Review, H1 2013

Indolent Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Indolent Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Osteosarcoma - Pipeline Review, H1 2013 Osteosarcoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H1 2013

Osteosarcoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Osteosarcoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Psychiatric Disorders - Pipeline Review, H1 2013 Psychiatric Disorders - Pipeline Review, H1 2013 - Product Thumbnail Image

Psychiatric Disorders - Pipeline Review, H1 2013

Psychiatric Disorders – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Psychiatric Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Ischemic Stroke - Pipeline Review, H1 2013 Ischemic Stroke - Pipeline Review, H1 2013 - Product Thumbnail Image

Ischemic Stroke - Pipeline Review, H1 2013

Ischemic Stroke – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ischemic Stroke - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Choroidal Neovascularization - Pipeline Review, H1 2013 Choroidal Neovascularization - Pipeline Review, H1 2013 - Product Thumbnail Image

Choroidal Neovascularization - Pipeline Review, H1 2013

Choroidal Neovascularization – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Choroidal Neovascularization - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Septic Shock - Pipeline Review, H1 2013 Septic Shock - Pipeline Review, H1 2013 - Product Thumbnail Image

Septic Shock - Pipeline Review, H1 2013

Septic Shock – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Septic Shock - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017 Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017 - Product Thumbnail Image

Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017

Chemical pharmaceutical is the main industry of China pharmaceutical market, occupying a pivotal position in the pharmaceutical industry With the improvement of the national economical development and...

April 2013
FROM

Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013

Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013" provides data on the Lennox-Gastaut...

April 2013
FROM

Tardive Dyskinesia Global Clinical Trials Review, H1, 2013

Tardive Dyskinesia Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H1, 2013" provides data on the Tardive Dyskinesia clinical...

April 2013
FROM

Partnerships, Licensing, Investments and M&A Deals and Trends for 03 - 2013 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals Summary Our “Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals”...

April 2013
FROM

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily...

April 2013
FROM

Dyslexia Global Clinical Trials Review, H1, 2013

Dyslexia Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Dyslexia Global Clinical Trials Review, H1, 2013" provides data on the Dyslexia clinical trial scenario. This report...

April 2013
FROM

Bronchospasm Global Clinical Trials Review, H1, 2013

Bronchospasm Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2013" provides data on the Bronchospasm clinical trial scenario....

April 2013
FROM

EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022

EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022 Chronic Myeloid Leukemia (CML) is a rare cancer of the white blood cells characterized by increased and unregulated growth of...

April 2013
FROM
Laboratory Information Management System Market in India 2013 Laboratory Information Management System Market in India 2013 - Product Thumbnail Image

Laboratory Information Management System Market in India 2013

The Laboratory Information Management System (LIMS) forms a niche market segment in India presently The growing systemization of laboratories will gradually steer forth the market The simultaneous rapid...

April 2013
FROM
Incontinence in Belarus Incontinence in Belarus - Product Thumbnail Image

Incontinence in Belarus

A key factor for the incontinence category in 2012 was its dependence on imports, and thus its vulnerability to currency fluctuations. A new factory manufacturing nappies/diapers and incontinence products...

April 2013
FROM
Vitamins and Dietary Supplements in Poland Vitamins and Dietary Supplements in Poland - Product Thumbnail Image

Vitamins and Dietary Supplements in Poland

Vitamins and dietary supplements enjoys positive development in Poland due to an expanding consumer base and growing frequency of usage. Alongside the increasing health consciousness, more Poles wish...

April 2013
FROM
Incontinence in Sweden Incontinence in Sweden - Product Thumbnail Image

Incontinence in Sweden

Sweden’s ageing population is the category’s key growth driver. However, the stigma associated with incontinence prevents many consumers from talking openly about the condition and seeking professional...

April 2013
FROM
Calming and Sleeping in Poland Calming and Sleeping in Poland - Product Thumbnail Image

Calming and Sleeping in Poland

A growing number of Poles are leading unbalanced and stressful lifestyles, working long hours and lacking the time for regular meals and proper relaxation. In addition, they do not undertake any physical...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos